Zai Lab Net Income vs. Return On Asset

ZLAB Stock  USD 18.09  -0.52  -2.79%   
Based on the measurements of profitability obtained from Zai Lab's financial statements, Zai Lab may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in April. Profitability indicators assess Zai Lab's ability to earn profits and add value for shareholders.
 
Net Loss  
 First Reported
2015-12-31
 Previous Quarter
-36 M
 Current Value
-50.4 M
 Quarterly Volatility
53.7 M
Macro event markers
 
Yuan Drop
 
Covid
 
Interest Hikes
Recent disclosures position Days Sales Outstanding within a decreasing cycle. Year-ago financials show Zai Lab with Days Sales Outstanding of 93.67. As of now, The current year's Days Of Sales Outstanding is projected to rise to 121.66, whereas Price To Sales Ratio is moving lower toward 3.96. Accumulated Other Comprehensive Income is projected to change by approximately 4.76% year over year. For the prior annual period, Accumulated Other Comprehensive Income came in at 29.7 Million. As of now, The current year's Total Other Income Expense Net is projected to rise to approximately 53.5 M, whereas Operating Income is moving lower toward about -240.9 M. Recent filings indicate that Gross Profit continues increasing. Gross Profit was pegged at 269.64 Million in the prior reporting cycle. As of now, The current year's Gross Profit Margin is projected to rise to 0.72, whereas Pretax Profit Margin is moving lower toward -0.41 .
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.720.5847
Fairly Up
Pretty Stable
Profitability metrics for Zai Lab relate earnings to revenue, assets, and equity. Values are computed from the latest available financial statement data.

Segment Revenue Profile

Revenue for Zai Lab breaks down into 4 product-level segments. Zejula accounts for approximately 59.8% of Zai Lab's revenue at 56.04 Million, while Nuzyra contributes 17.1% at 16 Million. Revenue distribution shows a leading segment without excessive concentration, suggesting moderate product diversification.
Your Current Watchlist.
For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.Zai Lab currently shows forward EPS consensus of -0.4698, with dispersion from -0.5 to -0.429. EPS TTM stands at -1.6. For Zai Lab, EPS is most informative when read together with margin stability and cash-flow conversion. The consensus EPS framework for Zai Lab is built on earnings figures that exclude non-recurring items. They can include expenses related to employee stock options. Values are derived from reported financial statements.
Macro event markers
 
Covid
 
Interest Hikes
The consensus EPS projection for Zai Lab is -0.4698 as of 30th of June 2026. This consensus view for Zai Lab incorporates analyst projections alongside historical variability data. Figures are sourced from regulatory filings and reported data..

Zai Lab Revenue by Earnings Segment Snapshot

This chart illustrates Zai Lab's revenue composition by product line based on the latest available data. Qinlock rounds out the mix at 10.3%, representing Zai Lab's smallest reported product line.
Earnings estimates add context for valuation and forward-looking analysis. This context is informational and can be reviewed with other metrics across periods. Values are drawn from reported financial data across periods. This view summarizes available data without implying outcomes.
 Earnings Share
-1.60
 Revenue Per Share
4.201
 Quarterly Revenue Growth
0.17
 Return On Assets
-0.12
 Return On Equity
-0.23
The market value of Zai Lab is measured differently than book value, which reflects Zai accounting equity. Zai Lab's market capitalization is 2.06 B. At P/B 2.88, Zai Lab trades moderately above book value. Enterprise value stands at 1.56 B. Intrinsic value for Zai Lab synthesizes operating data into a single estimate that complements price and book value. Reconciling these perspectives is central to structured valuation analysis. This view summarizes available data without implying outcomes.
Value and price for Zai Lab may converge over time but can differ substantially in any given period. For Zai Lab, key inputs include a P/B ratio of 2.88, a profit margin of -38.15%, ROE of -22.56%, and revenue of 460.16 M. Exchange pricing for Zai Lab reflects real-time supply and demand across active participants.

Zai Lab Return On Asset vs. Net Income Fundamental Analysis

Relative valuation benchmarks Zai Lab against sector multiples to estimate fair value.
Zai Lab is rated fourth in net income among leading competitors. It also is rated fourth in return on asset among leading competitors . Comparative financial data indicate that Net Loss is shifting by roughly 4.76%. Year-ago financials show Zai Lab with Net Loss of -175.54 Million. Valuation multiples such as P/E, P/B, and P/S compare Zai Lab to peer earnings performance.

Zai Return On Asset vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Zai Lab

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
-175.54 M
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Return on Assets (ROA) measures how efficiently a company generates profit relative to its total asset base. It is calculated by dividing net income by total assets and reflects management's effectiveness at deploying capital across the business. ROA is particularly useful for comparing companies within the same industry, since asset intensity varies widely across sectors.

Zai Lab

Return On Asset

 = 

Net Income

Total Assets

 = 
-0.12
A higher ROA indicates that each dollar of assets produces more income, which generally signals operational efficiency. Asset-heavy industries such as banking, utilities, and manufacturing tend to have lower ROAs than asset-light businesses like software or professional services. When ROA is low, it may indicate either underperforming operations or a capital-intensive business model that requires ongoing investment to sustain revenue.

Zai Return On Asset Comparison

Zai Lab is currently under evaluation in return on asset among leading competitors.

Zai Lab Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Zai Lab, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Zai Lab will eventually generate negative long term returns. The profitability progress is the general direction of Zai Lab's change in net profit over the period of time. It can combine multiple indicators of Zai Lab, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedEnd Of Year Estimate
Accumulated Other Comprehensive Income29.7 M31.2 M
Operating Income-229.4 M-240.9 M
Net Loss-175.5 M-184.3 M
Income Before Tax-178.5 M-187.4 M
Total Other Income Expense Net51 M53.5 M
Net Loss-399 M-379 M
Net Loss-175.5 M-184.3 M
Income Tax Expense-3.4 M-3.2 M
Net Interest Income27.8 M14.9 M
Interest Income33 M34.7 M
Change To Netincome153.7 M161.4 M
Net Loss-0.16 -0.17
Income Quality 0.86 0.62
Net Income Per E B T 0.89 0.82

Zai Profitability Driver Comparison

Profitability drivers are factors that directly affect the investment outlook for Zai Lab. Investors recognize that outcomes may not unfold as predicted, because unforeseen events and market disruptions can arise at any point and significantly alter the earnings trajectory.

Earnings Estimation Breakdown

The calculation of Zai Lab's earnings per share is based on data from the past 12 consecutive months used for reporting the company's financial figures. The next projected EPS of Zai Lab is estimated to be -0.4698 with the future projection ranging from a low of -0.5 to a high of -0.429. Please be aware that this consensus of annual earnings estimates for Zai Lab is based on EPS before non-recurring items.
Last Reported EPS
0.0
-0.5
Lowest
Expected EPS
-0.4698
-0.429
Highest

Earnings Projection Consensus

A consensus EPS-based estimate above Zai Lab's current price may suggest the market is pricing in excessive pessimism or overlooking near-term catalysts. Conversely, an estimate below market price could reflect a premium valuation that requires sustained earnings growth to justify. Both interpretations demand risk assessment and should not be acted upon in isolation.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 30th of June 2026Current EPS (TTM)
1169.52%
0.0
-0.4698
-1.6

Earnings per Share Projection vs Actual

When Zai Lab reports actual EPS, investors compare it against the analyst consensus estimate for Zai Lab to judge performance. A beat versus consensus is typically interpreted as positive execution; a miss signals a shortfall relative to expectations. EPS is expressed on a weighted average per-share basis to account for equity changes within the reporting period.

Estimated Months Earnings per Share

EPS serves income investors in Zai Lab as a quick gauge of dividend affordability: the higher the EPS relative to the dividend per share, the more cushion management has. However, accounting EPS can diverge from cash-based earnings, so investors should validate EPS signals with operating cash flow and capex data. Comparing Zai Lab's EPS to sector peers provides further context for dividend sustainability.

Quarterly Analyst Estimates and Surprise Metrics

Earnings surprise history for Zai Lab's reveals whether the company tends to guide conservatively or struggles to meet analyst expectations. A pattern of consistent beats signals strong management execution; repeated misses may indicate structural challenges. Analyst EPS estimates are formed from a combination of forward guidance, sector trends, and macroeconomic inputs.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
null
nullnullnullnull
2026-02-26
2025-12-31-0.3712-0.46-0.088823 
2025-11-06
2025-09-30-0.25-0.33-0.0832 
2025-08-07
2025-06-30-0.41-0.370.04
2025-05-06
2025-03-31-0.5475-0.450.097517 
2025-02-25
2024-12-31-0.6333-0.8-0.166726 
2024-11-12
2024-09-30-0.78-0.420.3646 
2024-08-06
2024-06-30-0.71-0.8-0.0912 
2024-05-08
2024-03-31-0.92-0.50.4245 
2024-02-27
2023-12-31-0.86-1.0-0.1416 
2023-11-07
2023-09-30-1.04-0.710.3331 
2023-08-07
2023-06-30-0.79-1.25-0.4658 
2023-05-09
2023-03-31-0.95-0.510.4446 
2023-03-01
2022-12-31-1.11-0.650.4641 
2022-11-09
2022-09-30-1.25-1.68-0.4334 
2022-08-09
2022-06-30-1.08-1.44-0.3633 
2022-05-10
2022-03-31-1.2-0.90.325 
2022-03-01
2021-12-31-1.33-2.17-0.8463 
2021-11-09
2021-09-30-1.18-1.010.1714 
2021-08-09
2021-06-30-1.3-1.76-0.4635 
2021-05-10
2021-03-31-1.58-2.64-1.0667 
2021-03-01
2020-12-31-0.99-0.39820.591859 
2020-12-02
2020-09-30-0.4-0.39820.0018
2020-08-13
2020-06-30-0.99-0.98991.0E-4
2020-06-03
2020-03-31-0.99-0.98991.0E-4
2020-03-19
2019-12-31-0.59-0.68-0.0915 
2019-11-27
2019-09-30-0.6-0.59530.0047
2019-09-03
2019-06-30-0.67-0.6717-0.0017
2019-05-29
2019-03-31-0.44-0.6717-0.231752 
2019-03-07
2018-12-31-0.45-2.32-1.87415 
2018-11-28
2018-09-30-0.4-0.330.0717 
2018-08-30
2018-06-30-0.26-0.83-0.57219 
2018-05-02
2018-03-31-0.18-0.29-0.1161 
2017-11-15
2017-09-30-0.23-0.210.02
2017-02-03
2016-12-310-0.76-0.76
2016-08-04
2016-06-300-0.24-0.24

Use Zai Lab in pair-trading

Pair analysis around Zai Lab matters because it can turn one security idea into a more market-neutral structure. Used properly, pair trading is less about prediction in isolation and more about identifying relative mispricing between related positions.

Zai Lab Pair Trading

Zai Lab Pair Trading Analysis

The ability to find closely correlated positions to Zai Lab could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Zai Lab when you sell it.
The correlation of Zai Lab is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1.
Hedging context for Zai Lab can be developed through Correlation analysis and pair trading analysis. Pair analysis can span stocks within the same sector or across different segments. Pair dynamics can shift during periods of market stress or structural change.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Zai Lab position

Zai Lab Healthcare sector classification and 2.06 Billion smaller-cap scale make it a natural anchor for themes targeting Biotechnology exposure. For Zai Lab in Biotechnology, the theme workflow defines the investment thesis first, then optimizes which Healthcare assets best express that view at the smaller-cap level.

Did You Try This Idea?

Run Energy Funds Thematic Idea Now

Energy Funds
Energy Funds Theme
Funds or Etfs investing in energy sector, natural resources, and ecology. The Energy Funds theme has 39 constituents at this time.
Whether used as a passive allocation or an active trading idea, the Energy Funds Theme provides a structured starting point for portfolio construction.
View All  Next Launch

More Resources for Zai Stock Analysis

A baseline understanding of Zai Lab is formed through its financial statements and trends. Ratios provide structure to financial performance and growth patterns. These metrics are based on Zai Lab's reported financial results.